“…10,16,18,[168][169][170][171][172][173][174][175][176][177][178][179][180][181][182][183] The motion of fluid inside the vitreous (intact or liquefied) due to eye rotation or saccadic eye movement has been investigated by many groups, 168,169,171,180,183 with particular implications shown for drug delivery and pharmacokinetics in the vitreous. 170,172,173,178,184 A model of enzymatic degradation of the vitreous was created and used to study the mobility of intravitreal nanoparticles, which could better simulate the biotransport of a therapeutic injected into aged and liquefied vitreous. 18 An in vitro ocular flow model called the PK-Eye was proposed for use in preclinical drug development, 175 which can allow for testing of therapeutics in vitreous substitutes.…”